MBRX Jonathan P Foster sells $0 worth of shares
Jun 24, 2025, 4:36 AM
0.00%
What does MBRX do
Moleculin Biotech, a Houston-based clinical-stage pharmaceutical company, focuses on developing treatments for tumors and viruses with three core technologies and six drug candidates. Established in 2016, it employs 18 people and has candidates showing human activity in trials.
Jonathan P Foster sold 540,540 shares of MBRX on 23 June at $0.00 per share, worth a total of $0. They now own 1,038,320 MBRX shares, or a 65% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.